Icosavax, Inc. Stock News

SEATTLE, March 02, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines aga

Newly IPO’ed biotech company Icosavax <> has recorded the biggest intraday gain since early December after Janus Henderson Group reported nearly 5% stake in the company. .

SEATTLE, Jan. 07, 2022 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines agai

- Dr. Shiver has contributed to the licensure of 14 pharmaceutical addressing global infectious diseases - - Dr. Shiver has contributed to the licensure of 14 pharmaceutical addressing global infectio

Icosavax Inc (NASDAQ:ICVX) shares gapped down prior to trading on Monday . The stock had previously closed at $22.95, but opened at $22.20. Icosavax shares last traded at $22.91, with a volume of 518 shares changing hands. Several brokerages have issued reports on ICVX. William Blair began coverage on shares of Icosavax in a research […]

Icosavax Inc (NASDAQ:ICVX)s stock price reached a new 52-week low during trading on Tuesday . The company traded as low as $19.54 and last traded at $20.34, with a volume of 5014 shares traded. The stock had previously closed at $23.06. A number of research firms recently commented on ICVX. William Blair began coverage on []

Icosavax Inc (ICVX) shares closed today 16.3% lower than it did at the end of yesterday. The stock is currently down 21.2% year-to-date, down 21.2% over the past 12 months, and down 21.2% over the past five years. Today, the Dow Jones Industrial Average rose 0.6%, and the S&P 500 rose 1.2%. Trading Activity Shares traded as high as $29.02 and as low as $20.07 this week.Shares closed 53.9% below its 52-week high and 14.9% above its 52-week low.Trading volume this week was 63.5% lower than the 10-day average and 21.8% lower than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price lags the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price lags the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Icosavax (NASDAQ:ICVX) and Enzon Pharmaceuticals (OTCMKTS:ENZN) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, dividends, valuation, analyst recommendations, institutional ownership, risk and profitability. Analyst Recommendations This is a breakdown of current recommendations for Icosavax and Enzon Pharmaceuticals, as reported []

Enzon Pharmaceuticals (OTCMKTS:ENZN) and Icosavax (NASDAQ:ICVX) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk. Analyst Recommendations This is a summary of current ratings and price targets for Enzon Pharmaceuticals and [] The post Enzon Pharmaceuticals (OTCMKTS:ENZN) & Icosavax (NASDAQ:ICVX) Head-To-Head Contrast appeared first on ETF Daily News .

Icosavax Inc (NASDAQ:ICVX) traded up 11.2% during trading on Friday . The company traded as high as $25.98 and last traded at $25.63. 4,419 shares traded hands during trading, a decline of 96% from the average session volume of 109,695 shares. The stock had previously closed at $23.04. A number of equities research analysts recently []

Icosavax Inc (ICVX) shares closed today 19.6% higher than it did at the end of yesterday. The stock is currently down 34.1% year-to-date, down 34.1% over the past 12 months, and down 34.1% over the past five years. Today, the Dow Jones Industrial Average fell 2.5%, and the S&P 500 fell 2.2%. Trading Activity Shares traded as high as $30.49 and as low as $20.07 this week.Shares closed 44.9% below its 52-week high and 37.3% above its 52-week low.Trading volume this week was 52.4% higher than the 10-day average and 152.9% higher than the 30-day average.Beta, a measure of the stocks volatility relative to the overall market stands at 0.0. Technical Indicators The Relative Strength Index (RSI) on the stock was between 30 and 70.MACD, a trend-following momentum indicator, indicates a downward trend.The stock closed below its Bollinger band, indicating it may be oversold. Market Comparative Performance The company's share price beats the S&P 500 Index today, lags it on a 1-year basis, and lags it on a 5-year basis The company's share price beats the Dow Jones Industrial Average today, lags it on a 1-year basis, and lags it on a 5-year basis This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to [email protected]. © 2020 Kwhen Inc.

Icosavax Inc (NASDAQ:ICVX) Analysts at William Blair decreased their FY2021 earnings per share estimates for Icosavax in a research report issued on Tuesday, November 16th. William Blair analyst A. Hsieh now expects that the company will earn ($3.82) per share for the year, down from their prior forecast of ($2.39). William Blair has a []

Icosavax Inc (NASDAQ:ICVX) Research analysts at William Blair reduced their FY2021 EPS estimates for Icosavax in a research note issued to investors on Tuesday, November 16th. William Blair analyst A. Hsieh now expects that the company will post earnings of ($3.82) per share for the year, down from their prior estimate of ($2.39). William []

Icosavax Inc (NASDAQ:ICVX) shares gapped down before the market opened on Thursday . The stock had previously closed at $28.30, but opened at $27.22. Icosavax shares last traded at $28.76, with a volume of 181 shares traded. Several equities research analysts have weighed in on ICVX shares. Cowen started coverage on Icosavax in a research []